Efgartigimod Alfa

Records for this ingredient, by country (identity only).

ATC L04AL01 · 9 markets · 21 records

Efgartigimod Alfa 9 markets · 21 records Forms
Filters
Kind

AU 4 records · 3 shown of 3 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

Only this ingredient

  • 20 mg/mL per mL / per unit basis not statedinjectionVYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial unknown
  • 200 mg/mL per mL / per unit basis not statedinjectionVYVGART efgartigimod alfa 1000 mg/5 mL solution for injection prefilled syringe unknown
  • 180 mg/mL per mL / per unit basis not statedinjectionVYVGART efgartigimod alfa 1000 mg/5.6 mL solution for injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 3 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

Only this ingredient

  • 20 mg per mL / per unit basis not statedinjectionVYVGART

Combination products containing this ingredient

  • 200 mg per mL / per unit basis not statedinjection CombinationEfgartigimod Alfa 200 mg + Hyaluronidase (Human Recombinant) 2,000 unitVYVGART Hytrulo
  • 180 mg per mL / per unit basis not statedinjection CombinationEfgartigimod Alfa 180 mg + Hyaluronidase (Human Recombinant) 2,000 unitVYVGART Hytrulo

JP 3 records · 3 shown of 3 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

Only this ingredient

  • 400 mg/20 mLinjectionウィフガート点滴静注400mg also in GB

Combination products containing this ingredient

  • 5.6 mL per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 5.6 mL + Efgartigimod Alfa 5.6 mLヒフデュラ配合皮下注
  • 5 mL per mL / per unit basis not statedinjection CombinationBerahyaluronidase Alfa 5 mL + Efgartigimod Alfa 5 mLヒフデュラ配合皮下注シリンジ

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

Only this ingredient

  • 400 mg/20 mLinjectionVyvgart 400mg/20ml concentrate for solution for infusion vials also in JP
  • 1,000 mg/5.6 mLinjectionVyvgart 1000mg/5.6ml solution for injection vials

CA 2 records · 2 shown of 2 Source Health Canada Drug Product Databas · Data as of 2026-10-23

Only this ingredient

  • 200 mg per mL / per unit basis not statedliquidVYVGART SC
  • 20 mg per mL / per unit basis not statedliquidVYVGART

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

Only this ingredient

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

Only this ingredient

  • 1,000 mg per mL / per unit basis not statedinjectionVYVGART 1000 mg, solution injectable
  • 400 mg per mL / per unit basis not statedinjectionVYVGART 20 mg/mL, solution à diluer pour perfusion

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

Only this ingredient

  • 20 mg/mL per mL / per unit basis not statedinjectionVYVGART CONCENTRATE FOR SOLUTION FOR INFUSION 20 MG/ML

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.